PRODUCTS

INTERNATIONAL  /  
PALIPERIDONE PALMITATE 3M
«  BACK TO "INTERNATIONAL"

Included in Global & USA Product Guide
Under development
Long-acting Injectable (LAI)
Product Pharmaceutical form Strengths Therapeutic category
  • Paliperidone Palmitate 3M
  • Long-acting Injectable
  • 175mg/syringe
  • 263mg/syringe
  • 350mg/syringe
  • 525mg/syringe
  • Treatment of schizophrenia in patients after they have been adequately treated with INVEGA SUSTENNA® (1-month paliperidone palmitate extended-release injectable suspension) for at least four months

Other products in "International"